imatinib mesylate has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachet, JB; Mas, L | 1 |
1 other study(ies) available for imatinib mesylate and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
[Advanced GIST: Which treatments in 2022?]
Topics: Antineoplastic Agents; Electron Transport Complex II; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Metabolism, Inborn Errors; Mitochondrial Diseases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-kit; Receptor, Platelet-Derived Growth Factor alpha; Succinate Dehydrogenase; Sunitinib | 2022 |